multicentre

多中心
  • 文章类型: Journal Article
    目的:本研究的目的是检查万古霉素和甲硝唑在艰难梭菌患者初次感染后无事件生存期(EFS)的验证性分析中的比较有效性(C.difficile)来自德国多中心队列研究。
    方法:IBIS多中心队列纳入了2017年8月至2020年9月CDI指数发作的患者。主要终点是EFS,定义为开始10天内对甲硝唑或万古霉素治疗的反应,治疗后90天内无任何原因的复发和死亡。使用具有治疗加权逆概率的Cox比例风险模型来研究该结果的比较有效性。此外,亚组分析基于严重和非严重感染进行.
    结果:在489名患者中,118(24%)接受甲硝唑的初始治疗,371(76%)接受万古霉素的初始治疗。其中,78/118(66.1%)和247/371(66.6%),分别,十天内对治疗有反应,既没有复发,也没有在90天内死亡,因此达到了EFS的结果.在非严重感染亚组中,74/293患者(25.3%)接受甲硝唑,219/293(74.7%)接受万古霉素治疗。其中,33/74(44.6%)甲硝唑患者和150/219(68.5%)万古霉素患者无事件存活。Cox比例风险模型揭示了总体人群和两个亚组的EFS差异(参考甲硝唑:所有严重程度:危险比[HR]0.46,[95%Cl0.33-0.65];非严重:HR0.39;[95%Cl0.24-0.60];严重:HR0.52;[95%Cl0.28-0.95])。
    结论:我们的分析证实了当前指南的变化,因为它支持万古霉素在所有严重程度上与甲硝唑相比的优越性。
    OBJECTIVE: The objective of this study is to examine the comparative effectiveness of vancomycin and metronidazole in a confirmatory analysis of event-free survival (EFS) following initial infection in patients with Clostridioides difficile (C. difficile) from a German multicentre cohort study.
    METHODS: The IBIS multicentre cohort enrolled patients with an index episode of CDI between August 2017 and September 2020. The primary endpoint was EFS, defined as response to treatment with metronidazole or vancomycin within ten days of initiation, absence of recurrence and death from any cause up to 90 days post-treatment. A Cox proportional hazards model with inverse probability of treatment weighting was used to investigate the comparative effectiveness of this outcome. Additionally, subgroup analyses were performed based on severe and non-severe infections.
    RESULTS: Of the 489 patients included, 118 (24%) received initial treatment with metronidazole and 371 (76%) with vancomycin. Of these, 78/118 (66.1%) and 247/371 (66.6%), respectively, responded to treatment within ten days, neither developed a recurrence nor died within 90 days and thus achieved the outcome of EFS. In the subgroup of non-severe infections, 74/293 patients (25.3%) received metronidazole, and 219/293 (74.7%) received vancomycin. Of these, 33/74 (44.6%) metronidazole patients and 150/219 (68.5%) vancomycin patients survived event-free. The Cox proportional hazards model revealed differences in EFS for the overall population and both sub-groups (reference metronidazole: all severity levels: hazard ratio [HR] 0.46, [95% Cl 0.33-0.65]; non-severe: HR 0.39; [95% Cl 0.24-0.60]; severe: HR 0.52; [95% Cl 0.28-0.95]).
    CONCLUSIONS: Our analysis confirms current changes in guidelines, as it supports the superiority of vancomycin compared to metronidazole across all severity levels.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:低磷血症在危重患者中很常见。我们已经描述了重症监护病房患者低磷酸盐血症的流行病学。
    方法:多中心,昆士兰州12个ICU的回顾性队列研究,澳大利亚1月1日2015年12月31日,2021年。排除包括再入院,肾脏替代疗法,终末期肾病,以及姑息性意图入院和从其他ICU转移。根据第一次低血清磷酸盐(PO4)的严重程度将患者分为四组:“无”(PO4:≥0.81mmol/L,“轻度”(PO4:≥0.50&<0.81mmol/L)“中度”(PO4:≥0.30&<0.50mmol/L)和“重度”(PO4:<0.30mmol/L)。混合效应逻辑回归模型,包括医院作为随机效应,旨在研究与90天病死率相关的因素。
    结果:在89,776例患者中,68,699名患者被纳入本研究,23,485人(34.2%)患有低磷酸盐血症,主要在ICU入院第2天发病,并在发现低磷酸盐血症3天后纠正至正常。参与磷酸盐替代的ICU之间存在很大差异;阈值,以及它被替换的路线。第90天病死率随低磷酸盐血症的严重程度而增加(无:3,974(8.8%),轻度:2,306(11%),中度:377(14%);重度:108(21%)(p<0.001))。多因素回归分析显示,与无低磷血症者相比,中度(比值比(OR)1.24;95%置信区间(CI)1.07~1.44;p=0.004)或重度(OR1.49;95%CI1.13~1.97;p=0.005)低磷酸盐血症患者90天病死率风险增加.
    结论:低磷血症很常见,主要发生在第2天,早期纠正血清磷酸盐。磷酸盐替代做法在ICU之间是可变的。中度和重度低磷血症与90天病死率增加相关。
    BACKGROUND: Hypophosphatemia is common in critically ill patients. We have described the epidemiology of hypophosphatemia in patients admitted to the Intensive Care Units.
    METHODS: A multicentre, retrospective cohort study of 12 ICUs in Queensland, Australia from January 1st, 2015, to December 31st, 2021. Exclusions included readmissions, renal replacement therapy, end-stage renal disease, and palliative intent admissions and transfers from other ICUs. Patients were classified into four groups based on the severity of the first episode of low serum phosphate (PO4): \"None\" (PO4: ≥ 0.81 mmol/L, ``Mild\" (PO4: ≥ 0.50 & < 0.81 mmol/L) \"Moderate\" (PO4: ≥ 0.30 & < 0.50 mmol/L) and \"Severe\" (PO4: < 0.30 mmol/L). A mixed-effect logistic regression model, including hospital as a random effect, was developed to examine factors associated with 90-day case fatality.
    RESULTS: Of the 89,776 patients admitted, 68,699 patients were included in this study, with 23,485 (34.2%) having hypophosphatemia with onset mostly on Day 2 of ICU admission and correcting to normal 3 days after hypophosphatemia was identified. There was substantial variation among participating ICUs in phosphate replacement; the threshold, and the route by which it was replaced. Day-90 case fatality increased with severity of hypophosphatemia (None: 3,974 (8.8%), Mild: 2,306 (11%), Moderate: 377 (14%); Severe: 108 (21%) (p < 0.001)). Multivariable regression analysis showed that compared to those without hypophosphatemia, patients with moderate (odds ratio (OR) 1.24; 95% confidence intervals (CI) 1.07-1.44; p = 0.004) or severe (OR 1.49; 95% CI 1.13-1.97; p = 0.005) hypophosphatemia had increased risk of 90-day case fatality.
    CONCLUSIONS: Hypophosphatemia was common, and mostly occurred on day 2 with early correction of serum phosphate. Phosphate replacement practices were variable among ICUs. Moderate and severe hypophosphatemia was associated with increased 90-day case fatality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    众所周知,COVID-19在其临床过程中是不可预测的。这种不可预测性对临床医生在预测将发展为严重病例并可能死于感染的患者方面提出了挑战。本研究旨在评估和比较NLR和SII作为预测COVID-19严重程度的生物标志物的诊断价值。以死亡率为代表,一项多中心比较研究,包括沙特阿拉伯的855名患者。使用描述性和分析性统计数据来比较幸存者和非幸存者之间的血液学指数。纳入患者的中位年龄为41岁,男女比例几乎相等。大多数参与者是沙特人,研究队列的死亡率为13.22%.非幸存者,与幸存者相比,明显更老,红细胞计数较低,血红蛋白和血细胞比容水平,以及显著较高的白细胞和中性粒细胞计数。NLR和SII都能够区分幸存者和非幸存者,后者具有明显更高的价值。然而,NLR在这种区分上优于SII,因为它在曲线下的面积更大。这项研究进一步证实了NLR和SII作为预测COVID-19严重程度和死亡率的生物标志物的诊断价值,NLR更加敏感和具体。通过利用NLR在COVID-19管理中的价值,管理COVID-19病例的临床指南应从这些发现中受益。
    COVID-19 has been notoriously unpredictable in its clinical course. Such unpredictability poses a challenge to clinicians in predicting patients who will develop severe cases and possibly die from the infection. This study aims to assess and compare the diagnostic value of the NLR and SII as biomarkers in predicting COVID-19 severity, represented by mortality, with a multicentre comparative study including 855 patients in Saudi Arabia. Descriptive and analytical statistics were used to compare haematological indices between survivors and non-survivors. The median age of patients included was 41 years old, with an almost equal ratio of men to women. Most participants were Saudis, and the mortality rate in the study cohort was 13.22%. Non-survivors, as compared to survivors, were significantly older, had lower RBC counts, haemoglobin and haematocrit levels, as well as significantly higher WBC and neutrophil counts. Both the NLR and SII were capable of differentiating between survivors and non-survivors, with the latter having significantly higher values. However, the NLR was superior to the SII in such differentiation, as it had a larger area under the curve. This study further confirms the diagnostic values of the NLR and SII as biomarkers in predicting COVID-19 severity and mortality, with the NLR being more sensitive and specific. Clinical guidelines on managing COVID-19 cases should benefit from these findings by harnessing the value of the NLR in COVID-19 management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:冠状动脉异常主动脉起源(AAOCA)是一组罕见的先天性心脏缺陷,具有多种临床表现。与AAOCA一起生活的个人的终生风险是未知的,迫切需要来自多中心注册中心的数据来适应当前的建议并指导最佳的患者管理。欧洲AAOCA注册中心(EURO-AAOCA)旨在评估各中心在AAOCA管理方面的差异。
    方法:EURO-AAOCA是一个前瞻性的,多中心注册,包括13个欧洲中心。在这里,我们评估了临床表现和管理方面的差异,2019年1月至2023年6月,各中心的治疗决策和手术结果。
    结果:纳入了262例AAOCA患者,年龄中位数为33岁(12-53),呈双峰分布。139例(53.1%)有症状,而胸痛(n=74,53.2%)是最常见的主诉,其次是晕厥(n=21,15.1%)。7名(5%)患者出现心肌梗死,2例(1.4%)心脏性猝死流产。右AAOCA(R-AAOCA)最常见(150,57.5%),其次是左AAOCA(L-AAOCA),占51(19.5%),和回旋-AAOCA(Cx-AAOCA)在20(7.7%)中。年龄组之间和各中心之间的诊断存在显着差异。74例(28.2%)患者接受了手术,无手术死亡;10例(3.8%)发生了轻微的术后并发症。
    结论:目前,欧洲中心之间在AAOCA变异的诊断方案和临床管理方面没有统一的协议。虽然在AAOCA手术是安全的,未来的纵向结局数据有望阐明如何最好地决定选择接受血运重建和保守治疗的患者.
    OBJECTIVE: Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European AAOCA Registry (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.
    METHODS: EURO-AAOCA is a prospective, multicentre registry including 13 European centres. Herein, we evaluated differences in clinical presentations and management, treatment decisions and surgical outcomes across centres from January 2019 to June 2023.
    RESULTS: A total of 262 AAOCA patients were included, with a median age of 33 years (12-53) with a bimodal distribution. One hundred thirty-nine (53.1%) were symptomatic, whereas chest pain (n = 74, 53.2%) was the most common complaint, followed by syncope (n = 21, 15.1%). Seven (5%) patients presented with a myocardial infarction, 2 (1.4%) with aborted sudden cardiac death. Right-AAOCA was most frequent (150, 57.5%), followed by left-AAOCA in 51 (19.5%), and circumflex AAOCA in 20 (7.7%). There were significant differences regarding diagnostics between age groups and across centres. Seventy-four (28.2%) patients underwent surgery with no operative deaths; minor postoperative complications occurred in 10 (3.8%) cases.
    CONCLUSIONS: Currently, no uniform agreement exists among European centres with regard to diagnostic protocols and clinical management for AAOCA variants. Although surgery is a safe procedure in AAOCA, future longitudinal outcome data will hopefully shed light on how to best decide towards optimal selection of patients undergoing revascularization versus conservative treatment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在为中国儿童侵袭性肺炎球菌病(IPD)的临床特征和肺炎链球菌分离株的分子特征提供资料。我们于2019年1月至2021年12月在中国19家医院进行了IPD的多中心前瞻性研究。人口统计数据,IPD的危险因素,死亡,收集和分析残疾。血清型,抗生素敏感性,还检测到肺炎球菌分离株的多位点序列分型(MLST)。共纳入478例IPD病例和355例肺炎球菌分离株。在患者中,260名男性,中位年龄为35个月(四分位距,12-46个月)。败血症(37.7%),脑膜炎(32.4%),肺炎(27.8%)是常见疾病类型,46例(9.6%)患者死于IPD。检测到34种血清型,19F(24.2%),14(17.7%),23F(14.9%),6B(10.4%)和19A(9.6%)是常见的血清型。肺炎球菌分离株对大环内酯类具有高度耐药性(98.3%),四环素(94.1%),甲氧苄啶/磺胺甲恶唑(70.7%)。非脑膜炎和脑膜炎分离株中青霉素的非敏感率分别为6.2%和83.3%。19F-ST271、19A-ST320和14-ST876显示出对抗生素的高抗性。这项多中心研究报告了IPD的临床特征,并证明了中国儿童肺炎球菌分离株的血清型分布和抗生素耐药性。有可能通过改善肺炎球菌疫苗的摄取来减少IPD,继续监视是有必要的。
    This study aimed to provide data for the clinical features of invasive pneumococcal disease (IPD) and the molecular characteristics of Streptococcus pneumoniae isolates from paediatric patients in China. We conducted a multi-centre prospective study for IPD in 19 hospitals across China from January 2019 to December 2021. Data of demographic characteristics, risk factors for IPD, death, and disability was collected and analysed. Serotypes, antibiotic susceptibility, and multi-locus sequence typing (MLST) of pneumococcal isolates were also detected. A total of 478 IPD cases and 355 pneumococcal isolates were enrolled. Among the patients, 260 were male, and the median age was 35 months (interquartile range, 12-46 months). Septicaemia (37.7%), meningitis (32.4%), and pneumonia (27.8%) were common disease types, and 46 (9.6%) patients died from IPD. Thirty-four serotypes were detected, 19F (24.2%), 14 (17.7%), 23F (14.9%), 6B (10.4%) and 19A (9.6%) were common serotypes. Pneumococcal isolates were highly resistant to macrolides (98.3%), tetracycline (94.1%), and trimethoprim/sulfamethoxazole (70.7%). Non-sensitive rates of penicillin were 6.2% and 83.3% in non-meningitis and meningitis isolates. 19F-ST271, 19A-ST320 and 14-ST876 showed high resistance to antibiotics. This multi-centre study reports the clinical features of IPD and demonstrates serotype distribution and antibiotic resistance of pneumococcal isolates in Chinese children. There exists the potential to reduce IPD by improved uptake of pneumococcal vaccination, and continued surveillance is warranted.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:已经提出了几种预测烧伤患者死亡风险的模型。然而,考虑所有这些患者的模型可能无法很好地预测大面积烧伤患者的死亡率.
    方法:这项回顾性多中心研究招募了2016年1月1日至2022年6月30日在华东地区三家医院接受治疗的大面积烧伤患者(≥50%的体表面积[TBSA])。通过绘制受试者工作特性(ROC)和校准曲线评估了六个预测模型的性能。通过“最小绝对收缩和选择算子”回归寻找潜在的预测因子。采用多因素logistic回归建立TBSA≥50%烧伤患者的预测模型。制备列线图,并通过参考ROC评估其性能,校准,和决策曲线。
    结果:共纳入465例符合资格的烧伤≥50%TBSA患者,其中139人(29.9%)死亡。FLAMES模型表现出最大的ROC曲线下面积(AUC)(0.875),其次是周等人的模型。(0.853)和ABSI模型(0.802)。Zhou等人的校准曲线。模型拟合良好;其他模型显著高估了死亡风险。新的列线图包括四个变量:年龄,%TBSA燃烧,全厚度烧伤的区域,和血乳酸。AUC(训练集0.889;内部验证集0.934;外部验证集0.890)和校准曲线表明,列线图表现出优异的辨别能力,并且预测非常准确。
    结论:对于TBSA≥50%的烧伤患者,周等人。和FLAMES模型对死亡率表现出相对较高的预测能力。新的列线图很敏感,具体,准确,并将有助于快速的临床决策。
    Several models predicting mortality risk of burn patients have been proposed. However, models that consider all such patients may not well predict the mortality of patients with extensive burns.
    This retrospective multicentre study recruited patients with extensive burns (≥ 50% of the total body surface area [TBSA]) treated in three hospitals of Eastern China from 1 January 2016 to 30 June 2022. The performances of six predictive models were assessed by drawing receiver operating characteristic (ROC) and calibration curves. Potential predictors were sought via \"least absolute shrinkage and selection operator\" regression. Multivariate logistic regression was employed to construct a predictive model for patients with burns to ≥ 50% of the TBSA. A nomogram was prepared and the performance thereof assessed by reference to the ROC, calibration, and decision curves.
    A total of 465 eligible patients with burns to ≥ 50% TBSA were included, of whom 139 (29.9%) died. The FLAMES model exhibited the largest area under the ROC curve (AUC) (0.875), followed by the models of Zhou et al. (0.853) and the ABSI model (0.802). The calibration curve of the Zhou et al. model fitted well; those of the other models significantly overestimated the mortality risk. The new nomogram includes four variables: age, the %TBSA burned, the area of full-thickness burns, and blood lactate. The AUCs (training set 0.889; internal validation set 0.934; external validation set 0.890) and calibration curves showed that the nomogram exhibited an excellent discriminative capacity and that the predictions were very accurate.
    For patients with burns to ≥ 50%of the TBSA, the Zhou et al. and FLAMES models demonstrate relatively high predictive ability for mortality. The new nomogram is sensitive, specific, and accurate, and will aid rapid clinical decision-making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Multicenter Study
    背景:已知患者因素有助于踝关节骨折的决策和治疗。基线流动性差的存在,糖尿病,神经病,酗酒,认知障碍,炎性关节炎或多发性创伤可导致更高的失败或并发症的风险。对于本文描述为复杂踝关节骨折的这一具有挑战性的患者队列,可获得的最佳管理证据有限。这项英国多中心研究评估并评估了因严重合并症和患者因素而并发的踝关节骨折的流行病学,并使用了专业的手术技术,例如后足钉(HFN)/胫骨跟骨(TCC)钉和增强的切开复位和内固定(ORIF)。
    方法:对成人远端AO43/AO44骨折进行了一项英国范围的合作研究,与上述1个或多个患者因素相关。主要结果包括患者人口统计学,合并症,外科技术和植入物。次要结果包括手术并发症和术后早期负重说明。进行统计分析以评估患者和骨折特征的结果,包括倾向匹配。
    结果:一千三百六十位患者,至少有上述复杂因素之一,纳入了56个中心的平均年龄为53.1岁.90.2%(1227)的患者接受了一期内固定,其中78.9%(1073)的标准切开复位内固定(ORIF),3.25%(43)延长ORIF和8.1%(111)原HFN/TCC。后足钉组和ORIF组的总体伤口并发症和血栓栓塞事件相似(11.7%vs10.7%)。糖尿病患者的伤口并发症高于非糖尿病患者,与固定方法无关(15.8%vs9.0%)。合并症和骨折类型倾向匹配后,后足甲组(11.8%)和延长ORIF组(16.7%)的总体并发症较低,高于标准ORIF组(18.6%)。
    结论:只有少数复杂踝关节骨折采用专业技术(HFN/TCC或延长ORIF)治疗。尽管在老年和体弱的患者中更常用,但他们的感知优势通常被不愿尽早承受体重所抵消。与标准ORIF相比,这些技术显示出更好的并发症情况,但是具有关节融合准备的后足钉比用于固定的后足钉具有更多的并发症。
    方法:III.
    BACKGROUND: Patient factors are known to contribute to decision making and treatment of ankle fractures. The presence of poor baseline mobility, diabetes, neuropathy, alcoholism, cognitive impairment, inflammatory arthritis or polytrauma can result in a higher risk of failure or complications. Limited evidence is available on the optimum management for this challenging cohort of patients herein described as complex ankle fractures. This UK multicentre study assessed and evaluated the epidemiology of ankle fractures complicated by significant comorbidity and patient factors and use of specialist surgical techniques such as hindfoot nails (HFN) / tibiotalarcalcaneal (TCC) nails and enhanced open reduction and internal fixation (ORIF).
    METHODS: A UK-wide collaborative study was performed of adult distal AO43/AO44 fractures, associated with 1 or more of the patient factors listed above. Primary outcomes included patient demographics, comorbidities, surgical technique and implants. Secondary outcomes included surgical complications and early post-operative weight bearing instructions. Statistical analysis was performed to assess patient and fracture characteristics on outcome, including propensity matching.
    RESULTS: One-thousand three hundred and sixty patients, with at least one of the above complex factors, from 56 centres were included with a mean age of 53.1 years. 90.2% (1227) patients underwent primary fixation which included 78.9% (1073) standard open reduction internal fixations (ORIF), 3.25% (43) extended ORIF and 8.1% (111) primary HFN / TCC. Overall wound complications and thromboembolic events were similar in the hindfoot nail group and the ORIF group (11.7% vs 10.7%). Wound complications were greater in diabetic patients versus non-diabetic patients independent of fixation method (15.8% vs 9.0%). After propensity matching for comorbidities and fracture type, overall complications were lower in the hindfoot nail (11.8%) and extended ORIF groups (16.7%), than the standard ORIF group (18.6%).
    CONCLUSIONS: Only a minority of complex ankle fractures are treated with specialised techniques (HFN/TCC or extended ORIF). Though more commonly used in older and frail patients their perceived advantages are often negated by a reluctance to bear weight early. These techniques demonstrated a better complication profile to standard ORIF but hindfoot nail with joint preparation for fusion was associated with more complications than hindfoot nail for fixation.
    METHODS: III.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Randomized Controlled Trial
    背景:重症监护病房获得性虚弱(ICU-AW)是ICU患者中普遍存在且严重的问题。抗阻训练和β-羟基-β-甲基丁酸(HMB)干预已证明有可能增强肌肉减少症患者和老年人的肌肉功能。这项研究的目的是确定阻力训练和/或HMB管理是否会改善身体功能,肌肉力量,内科ICU患者的生活质量。
    方法:在这个多中心中,四臂,单盲随机对照试验,我们共纳入了112例入住ICU的内科诊断成年患者.然后将这些参与者随机分配到四个治疗组之一:阻力训练组接受基于协议的多级阻力运动,HMB组接受3克/天的HMBCa,联合组和对照组接受标准护理,从ICU到普通病房直到出院。出院时评估的主要结果包括六分钟步行距离(6MWD)和短物理性能电池(SPPB)。测量的次要结果包括肌肉质量,MRC得分,握力,健康报告不同时间点的生活质量。使用广义线性混合模型进行数据分析,坚持意向对待分析的原则。
    结果:阻力训练和联合治疗组的SPPB评分显着增加(3.848和2.832分,分别)与对照组相比,6WMD(99.768和88.577m,分别)(均P<0.01)。然而,HMB组无明显变化.肌肉力量,如在ICU和出院时进行的MRC和握力测试所示,抗阻训练组和联合组的改善具有统计学意义(P<0.05)。然而,在60天死亡率方面,治疗组和常规治疗之间没有发现显着差异,ICU-AW的患病率,肌肉质量,生活质量,或其他功能方面。
    结论:在整个住院干预期间,使用或不使用β-羟基-β-甲基丁酸的阻力训练可改善内科ICU患者的身体功能和肌肉力量,但是肌肉质量,生活质量,60天死亡率未受影响。
    背景:ChiCTR2200057685于3月15日注册,2022年。
    Intensive care unit-acquired weakness (ICU-AW) is a prevalent and severe issue among ICU patients. Resistance training and beta-hydroxy-beta-methylbutyrate (HMB) intervention have demonstrated the potential to enhance muscle function in patients with sarcopenia and in older adults. The purpose of this study was to determine whether resistance training and/or HMB administration would improve physical function, muscle strength, and quality of life in medical ICU patients.
    In this multicentre, four-arm, single-blind randomised control trial, a total of 112 adult patients with internal medical diagnoses admitted to the ICU were enrolled. These participants were then randomly assigned to one of four treatment groups: the resistance training group received protocol-based multilevel resistance exercise, the HMB group received 3 g/day of HMBCa, combination group and control groups received standard care, from the ICU to the general ward until discharge. The primary outcomes assessed at discharge included six-minute walking distance (6MWD) and short physical performance battery (SPPB). Secondary outcomes measured included muscle mass, MRC score, grip strength, and health reports quality of life at different time points. Data analysis was performed using a generalised linear mixed model, adhering to the principles of intention-to-treat analysis.
    Resistance training and combination treatment groups exhibited significant increases in SPPB scores (3.848 and 2.832 points, respectively) compared to the control group and substantial improvements in 6WMD (99.768 and 88.577 m, respectively) (all with P < 0.01). However, no significant changes were observed in the HMB group. Muscle strength, as indicated by MRC and grip strength tests conducted at both ICU and hospital discharge, showed statistically significant improvements in the resistance training and combination groups (P < 0.05). Nevertheless, no significant differences were found between the treatment groups and usual care in terms of 60-day mortality, prevalence of ICU-AW, muscle mass, quality of life, or other functional aspects.
    Resistance training with or without beta-hydroxy-beta-methylbutyrate during the entire hospitalisation intervention improves physical function and muscle strength in medical ICU patients, but muscle mass, quality of life, and 60-day mortality were unaffected.
    ChiCTR2200057685 was registered on March 15th, 2022.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    先前的一项研究比较了印度青少年1型糖尿病(T1D)中检测双重糖尿病(DD)的胰岛素敏感性指数,并得出了一个临界值,以预测T1D青少年中代谢综合征(MS)发展的未来风险。我们进行了当前的研究,目的是验证这些截止值,以在来自不同地理位置的T1D印度受试者中检测DD。
    这项多中心横断面研究包括161名患有T1D的印度青少年。人口统计,人体测量学,临床,使用标准方案收集生化数据。使用各种方程式计算胰岛素敏感性(IS)以确定患有T1D的受试者中的胰岛素敏感性。使用2017年国际糖尿病联合会(IDF)共识定义诊断代谢综合征。
    我们报告了患有T1D的印度青少年中MS的患病率为4.3%,另外29.8%的研究参与者有发生MS的风险。低高密度脂蛋白(HDL)(23.6%)是MS定义中最常见的异常成分。通过SEARCH组得出的方程计算的胰岛素敏感性是识别患有T1D的印度青少年中MS和代谢风险的最合适指标。建议的截止值5.48具有很高的特异性,正预测值,在识别DD发展风险方面具有阴性预测值。
    通过SEARCH小组提出的公式计算的胰岛素敏感性以及早期研究中得出的截止值可以有效地用于识别来自不同地理位置的T1D印度青少年MS/DD发展的风险。
    UNASSIGNED: A previous study compared insulin sensitivity indices for the detection of double diabetes (DD) in Indian adolescents with type-1 diabetes (T1D) and derived a cut-off to predict future risk for the development of metabolic syndrome (MS) in adolescents with T1D. We conducted the current study with the aim to validate these cut-offs for detecting DD among Indian subjects with T1D from various geographical locations.
    UNASSIGNED: This multicentric cross-sectional study included 161 Indian adolescents with T1D. Demographic, anthropometric, clinical, and biochemical data were collected using standard protocols. Insulin sensitivity (IS) was calculated using various equations developed to determine insulin sensitivity in subjects with T1D. Metabolic syndrome was diagnosed using International Diabetes Federation (IDF) Consensus Definition 2017.
    UNASSIGNED: We report 4.3% prevalence of MS in Indian adolescents with T1D with an additional 29.8% of study participants at risk of development of MS. Low High density lipoprotein (HDL) (23.6%) was the commonest abnormal component of the MS definition. Insulin sensitivity calculated by an equation derived by the SEARCH group was the most appropriate index to identify MS and metabolic risk in Indian adolescents with T1D. The proposed cut-off of 5.48 had high specificity, positive predictive value, and negative predictive value in identifying the risk of the development of DD.
    UNASSIGNED: Insulin sensitivity calculated by the equation proposed by the SEARCH group together with cut-offs derived in earlier study may be used effectively to identify risk of development of MS/DD in Indian adolescents with T1D from various geographical locations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:咽喉癌(LPC)包括喉癌和下咽癌,早期诊断可明显改善患者的预后和生活质量。在喉镜引导下对可疑癌组织进行病理活检是诊断LPC的金标准。然而,这种主观检查在很大程度上取决于喉科医师的技能和经验,这增加了漏诊和重复不必要活检的可能性。我们旨在开发和验证基于深度卷积神经网络的喉咽人工智能诊断系统(LPAIDS),用于实时自动识别喉镜白光成像(WLI)和窄带成像(NBI)图像中的LPC,以提高LPC的诊断准确性通过减少专家喉科医师之间的诊断差异。
    方法:所有来自2382名患者的31,543张喉镜图像被分类为训练,验证,和要开发的测试集,验证,和内部测试LPAIDS。来自其他五家医院的另外25,063张图像被用作外部测试。总的来说,551个视频用于评估系统的实时性能,并使用200个随机选择的视频来比较LPAIDS与喉科医师的诊断性能。使用WLI(模型W)或NBI(模型N)图像构建了两个深度学习模型,以与LPAIDS进行比较。
    结果:LPAIDS比W和N型具有更高的诊断性能,在内部图像和视频测试中,精度为0·956和0·949,分别。在接收器工作特征曲线下面积值为0·965-0·987的外部集合中验证了LPAIDS的鲁棒性和稳定性。在喉科医生-机器比赛中,LPAIDS的准确度为0·940,与专家喉科医师相当,优于其他具有不同资格的喉科医师。
    结论:LPAIDS在实时检测LPC方面具有很高的准确性和稳定性,这显示了使用LPAIDS通过减少专家喉科医师之间的诊断差异来提高LPC诊断准确性的巨大潜力。
    Laryngopharyngeal cancer (LPC) includes laryngeal and hypopharyngeal cancer, whose early diagnosis can significantly improve the prognosis and quality of life of patients. Pathological biopsy of suspicious cancerous tissue under the guidance of laryngoscopy is the gold standard for diagnosing LPC. However, this subjective examination largely depends on the skills and experience of laryngologists, which increases the possibility of missed diagnoses and repeated unnecessary biopsies. We aimed to develop and validate a deep convolutional neural network-based Laryngopharyngeal Artificial Intelligence Diagnostic System (LPAIDS) for real-time automatically identifying LPC in both laryngoscopy white-light imaging (WLI) and narrow-band imaging (NBI) images to improve the diagnostic accuracy of LPC by reducing diagnostic variation among on-expert laryngologists.
    All 31,543 laryngoscopic images from 2382 patients were categorised into training, verification, and test sets to develop, validate, and internal test LPAIDS. Another 25,063 images from five other hospitals were used as external tests. Overall, 551 videos were used to evaluate the real-time performance of the system, and 200 randomly selected videos were used to compare the diagnostic performance of the LPAIDS with that of laryngologists. Two deep-learning models using either WLI (model W) or NBI (model N) images were constructed to compare with LPAIDS.
    LPAIDS had a higher diagnostic performance than models W and N, with accuracies of 0·956 and 0·949 in the internal image and video tests, respectively. The robustness and stability of LPAIDS were validated in external sets with the area under the receiver operating characteristic curve values of 0·965-0·987. In the laryngologist-machine competition, LPAIDS achieved an accuracy of 0·940, which was comparable to expert laryngologists and outperformed other laryngologists with varying qualifications.
    LPAIDS provided high accuracy and stability in detecting LPC in real-time, which showed great potential for using LPAIDS to improve the diagnostic accuracy of LPC by reducing diagnostic variation among on-expert laryngologists.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号